142 related articles for article (PubMed ID: 33116878)
1. Overexpression of Cancer Upregulated Gene 2 (CUG2) Decreases Spry2 Through c-Cbl, Leading to Activation of EGFR and β-Catenin Signaling.
Yawut N; Kaewpiboon C; Budluang P; Cho IR; Kaowinn S; Koh SS; Chung YH
Cancer Manag Res; 2020; 12():10243-10250. PubMed ID: 33116878
[TBL] [Abstract][Full Text] [Related]
2. Increased EGFR expression induced by a novel oncogene, CUG2, confers resistance to doxorubicin through Stat1-HDAC4 signaling.
Kaowinn S; Jun SW; Kim CS; Shin DM; Hwang YH; Kim K; Shin B; Kaewpiboon C; Jeong HH; Koh SS; Krämer OH; Johnston RN; Chung YH
Cell Oncol (Dordr); 2017 Dec; 40(6):549-561. PubMed ID: 28776259
[TBL] [Abstract][Full Text] [Related]
3. CGK062, a small chemical molecule, inhibits cancer upregulated gene 2‑induced oncogenesis through NEK2 and β‑catenin.
Kaowinn S; Oh S; Moon J; Yoo AY; Kang HY; Lee MR; Kim JE; Hwang DY; Youn SE; Koh SS; Chung YH
Int J Oncol; 2019 Apr; 54(4):1295-1305. PubMed ID: 30968157
[TBL] [Abstract][Full Text] [Related]
4. Cancer upregulated gene (CUG)2 elevates YAP1 expression, leading to enhancement of epithelial-mesenchymal transition in human lung cancer cells.
Kaowinn S; Yawut N; Koh SS; Chung YH
Biochem Biophys Res Commun; 2019 Mar; 511(1):122-128. PubMed ID: 30771899
[TBL] [Abstract][Full Text] [Related]
5. STAT1‑HDAC4 signaling induces epithelial‑mesenchymal transition and sphere formation of cancer cells overexpressing the oncogene, CUG2.
Kaowinn S; Kaewpiboon C; Koh SS; Krämer OH; Chung YH
Oncol Rep; 2018 Nov; 40(5):2619-2627. PubMed ID: 30226605
[TBL] [Abstract][Full Text] [Related]
6. Translocalization of enhanced PKM2 protein into the nucleus induced by cancer upregulated gene 2 confers cancer stem cell-like phenotypes.
Yawut N; Kaowinn S; Cho IR; Budluang P; Kim S; Kim S; Youn SE; Koh SS; Chung YH
BMB Rep; 2022 Feb; 55(2):98-103. PubMed ID: 35000669
[TBL] [Abstract][Full Text] [Related]
7. Cancer upregulated gene 2 induces epithelial-mesenchymal transition of human lung cancer cells via TGF-β signaling.
Kaowinn S; Kim J; Lee J; Shin DH; Kang CD; Kim DK; Lee S; Kang MK; Koh SS; Kim SJ; Chung YH
Oncotarget; 2017 Jan; 8(3):5092-5110. PubMed ID: 27974707
[TBL] [Abstract][Full Text] [Related]
8. N-Benzyl-N-methyl-dodecan-1-amine, a novel compound from garlic, exerts anti-cancer effects on human A549 lung cancer cells overexpressing cancer upregulated gene (CUG)2.
Kaowinn S; Kaewpiboon C; Kim JE; Lee MR; Hwang DY; Choi YW; Kim HW; Park JK; Song KM; Lee NH; Maeng JS; Chung YH
Eur J Pharmacol; 2018 Dec; 841():19-27. PubMed ID: 30287155
[TBL] [Abstract][Full Text] [Related]
9. Cancer upregulated gene 2 (CUG2), a novel oncogene, promotes stemness-like properties via the NPM1-TGF-β signaling axis.
Kaowinn S; Seo EJ; Heo W; Bae JH; Park EJ; Lee S; Kim YJ; Koh SS; Jang IH; Shin DH; Chung YH
Biochem Biophys Res Commun; 2019 Jul; 514(4):1278-1284. PubMed ID: 31113615
[TBL] [Abstract][Full Text] [Related]
10. Elevated Expression of JMJD5 Protein Due to Decreased miR-3656 Levels Contributes to Cancer Stem Cell-Like Phenotypes under Overexpression of Cancer Upregulated Gene 2.
Yawut N; Cho IR; Budluang P; Kaowinn S; Kaewpiboon C; Jeon B; Kim SW; Kang HY; Kang MK; Koh SS; Chung YH
Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053270
[TBL] [Abstract][Full Text] [Related]
11. Suppression of autophagic genes sensitizes CUG2-overexpressing A549 human lung cancer cells to oncolytic vesicular stomatitis virus-induced apoptosis.
Malilas W; Koh SS; Lee S; Srisuttee R; Cho IR; Moon J; Kaowinn S; Johnston RN; Chung YH
Int J Oncol; 2014 Apr; 44(4):1177-84. PubMed ID: 24452380
[TBL] [Abstract][Full Text] [Related]
12. Cancer upregulated gene 2, a novel oncogene, enhances migration and drug resistance of colon cancer cells via STAT1 activation.
Malilas W; Koh SS; Kim S; Srisuttee R; Cho IR; Moon J; Yoo HS; Oh S; Johnston RN; Chung YH
Int J Oncol; 2013 Oct; 43(4):1111-6. PubMed ID: 23917355
[TBL] [Abstract][Full Text] [Related]
13. Sprouty2 protein enhances the response to gefitinib through epidermal growth factor receptor in colon cancer cells.
Feng YH; Tsao CJ; Wu CL; Chang JG; Lu PJ; Yeh KT; Shieh GS; Shiau AL; Lee JC
Cancer Sci; 2010 Sep; 101(9):2033-8. PubMed ID: 20624167
[TBL] [Abstract][Full Text] [Related]
14. MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2.
He Y; Ge Y; Jiang M; Zhou J; Luo D; Fan H; Shi L; Lin L; Yang L
Cell Physiol Biochem; 2018; 47(4):1465-1481. PubMed ID: 29949784
[TBL] [Abstract][Full Text] [Related]
15. Intersectin 1 enhances Cbl ubiquitylation of epidermal growth factor receptor through regulation of Sprouty2-Cbl interaction.
Okur MN; Ooi J; Fong CW; Martinez N; Garcia-Dominguez C; Rojas JM; Guy G; O'Bryan JP
Mol Cell Biol; 2012 Feb; 32(4):817-25. PubMed ID: 22158968
[TBL] [Abstract][Full Text] [Related]
16. ING5 inhibits lung cancer invasion and epithelial-mesenchymal transition by inhibiting the WNT/β-catenin pathway.
Liu XL; Meng J; Zhang XT; Liang XH; Zhang F; Zhao GR; Zhang T
Thorac Cancer; 2019 Apr; 10(4):848-855. PubMed ID: 30810286
[TBL] [Abstract][Full Text] [Related]
17. Cancer upregulated gene 2, a novel oncogene, confers resistance to oncolytic vesicular stomatitis virus through STAT1-OASL2 signaling.
Malilas W; Koh SS; Srisuttee R; Boonying W; Cho IR; Jeong CS; Johnston RN; Chung YH
Cancer Gene Ther; 2013 Feb; 20(2):125-32. PubMed ID: 23306614
[TBL] [Abstract][Full Text] [Related]
18. Regulation of EGFR trafficking and cell signaling by Sprouty2 and MIG6 in lung cancer cells.
Walsh AM; Lazzara MJ
J Cell Sci; 2013 Oct; 126(Pt 19):4339-48. PubMed ID: 23868981
[TBL] [Abstract][Full Text] [Related]
19. Direct binding of PP2A to Sprouty2 and phosphorylation changes are a prerequisite for ERK inhibition downstream of fibroblast growth factor receptor stimulation.
Lao DH; Yusoff P; Chandramouli S; Philp RJ; Fong CW; Jackson RA; Saw TY; Yu CY; Guy GR
J Biol Chem; 2007 Mar; 282(12):9117-26. PubMed ID: 17255109
[TBL] [Abstract][Full Text] [Related]
20. Sprouty2 inhibits amphiregulin-induced down-regulation of E-cadherin and cell invasion in human ovarian cancer cells.
Cheng JC; Chang HM; Xiong S; So WK; Leung PC
Oncotarget; 2016 Dec; 7(49):81645-81660. PubMed ID: 27835572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
